FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

FDA Creating Agency-Level Office of Digital Transformation

FDA creates an Office of Digital Transformation, reporting to the commissioner, as part of its ongoing information technology and data modernization e...

Medical Devices

Revised Guide on Face Mask Enforcement Policy

FDA posts a revised guidance entitled Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During ...

Human Drugs

Provide Consistent Info to FDA and USPTO: Attorneys

Three Cooley attorneys say a recent Court of Appeals for the Federal Circuit decision shows how giving inconsistent information to FDA and the U.S. Pa...

Human Drugs

Dont Change 180-day Generic Exclusivity: Yale Journal

Researchers say they see no evidence of continuing problems with generic drug 180-day exclusivity parking that require a congressional solution.

Human Drugs

Astellas ASPIRO Trial Patient Dies

Astellas says an ASPIRO trial patient whose serious adverse event led to the trial being paused and an FDA clinical hold has died.

Biologics

Scalise, Comer Ask FDA About Biden Booster Shot Push

Two leading House Republicans ask FDA for information on the pressure they say may have come from the White House to approve Covid vaccine booster sho...

Human Drugs

FDA Sees Patents Boosting Drug Competition

FDA acting commissioner Janet Woodcock asks the U.S. Patent and Trademark Office to open a dialog on how the two agencies can work together to promote...

Human Drugs

Jacobus Pharma Recalls 3 Ruzurgi Lots

Jacobus Pharmaceutical recalls three lots of Ruzurgi (amifampridine) 10 mg tablets due to potential contamination with yeast, mold, and aerobic bacter...

Medical Devices

inTravent SoloPass Brain Imager Cleared

FDA clears an inTravent Medical Partners 510(k) for the SoloPass system for aiding in the frontal placement of intra-ventricular catheters.

Human Drugs

Axsome NDA Filed for Migraine Therapy

FDA accepts for review an Axsome Therapeutics NDA for AXS-07 (meloxicam-rizatriptan) for treating migraine headaches.